Global Change Assessments in Anti-Alzheimer Clinical Drug Trials

Publisher： Karger

E-ISSN： 1421-9824|9|3|8-15

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.9, Iss.3, 1998-10, pp. : 8-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessing the Clinical Importance of Statistically Significant Improvement in Anti-Dementia Drug Trials

By  

Neuroepidemiology, Vol. 20, Iss. 2, 2001-05 ,pp. : 51-56

Karger

Access to resources Recommend Favorite

Determinants of Global Clinical Change Assessment in Patients with Early Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-04 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Agreement in Cognitive and Clinical Assessments in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 4, 2009-03 ,pp. : 344-352

Karger

Access to resources Recommend Favorite

Effects of Rivastigmine Transdermal Patch and Capsule on Aspects of Clinical Global Impression of Change in Alzheimer’s Disease: A Retrospective Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 29, Iss. 5, 2010-05 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

Global Clinical Trials for the Treatment of TB with Thioridazine

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 99-103

Bentham Science Publishers

Access to resources Recommend Favorite